Artificial-intelligence-driven discovery of prognostic biomarker for sarcopenia.
Journal:
Journal of cachexia, sarcopenia and muscle
Published Date:
Oct 26, 2021
Abstract
BACKGROUND: Sarcopenia is defined as muscle wasting, characterized by a progressive loss of muscle mass and function due to ageing. Diagnosis of sarcopenia typically involves both muscle imaging and the physical performance of people exhibiting signs of muscle weakness. Despite its worldwide prevalence, a molecular method for accurately diagnosing sarcopenia has not been established.